Ethics and policy issues for stem cell research and pulmonary medicine.

Chest
Justin Lowenthal, Jeremy Sugarman

Abstract

Stem cell research and related initiatives in regenerative medicine, cell-based therapy, and tissue engineering have generated considerable scientific and public interest. Researchers are applying stem cell technologies to chest medicine in a variety of ways: using stem cells as models for drug discovery, testing stem cell-based therapies for conditions as diverse as COPD and cystic fibrosis, and producing functional lung and tracheal tissue for physiologic modeling and potential transplantation. Although significant scientific obstacles remain, it is likely that stem cell-based regenerative medicine will have a significant clinical impact in chest medicine. However, stem cell research has also generated substantial controversy, posing a variety of ethical and regulatory challenges for research and clinical practice. Some of the most prominent ethical questions related to the use of stem cell technologies in chest medicine include (1) implications for donors, (2) scientific prerequisites for clinical testing and use, (3) stem cell tourism, (4) innovation and clinical use of emerging stem cell-based interventions, (5) responsible translation of stem cell-based therapies to clinical use, and (6) appropriate and equitable access t...Continue Reading

References

May 8, 2000·Nursing·M Fountain
Aug 7, 2003·Trends in Biotechnology·Philippe Collas, Anne-Mari Håkelien
Jan 6, 2005·Journal of the American College of Surgeons·Angelique M Reitsma, Jonathan D Moreno
Apr 11, 2007·Nature Biotechnology·Patrick L Taylor
Jul 20, 2007·Regenerative Medicine·Síle LaneAnne E Bishop
Feb 21, 2008·Stem Cell Reviews·Jennifer Hipp, Anthony Atala
May 27, 2008·Journal of the American College of Surgeons·Walter L BifflUNKNOWN Society of University Surgeons Surgical Innovations Project Team
Aug 8, 2008·Proceedings of the American Thoracic Society·Joan E Nichols, Joaquin Cortiella
Dec 2, 2008·Cell Stem Cell·Darren LauTimothy Caulfield
Jan 7, 2009·Therapeutic Advances in Respiratory Disease·Dario SiniscalcoBruno D'Agostino
Apr 16, 2009·Pediatrics·Lara J AkinbamiEdward J Sondik
Mar 21, 2009·Science·Sorapop Kiatpongsan, Douglas Sipp
Apr 8, 2009·The Lancet Oncology·Norra MacReady
Jun 18, 2009·Current Opinion in Pulmonary Medicine·deNay P Kirkpatrick, Mark T Dransfield
Jun 27, 2009·Science·Olle Lindvall, Insoo Hyun
Sep 11, 2009·Nature Biotechnology·Jane Qiu
Mar 25, 2010·BMJ : British Medical Journal·Jeremy Laurance
Apr 14, 2010·Expert Opinion on Biological Therapy·Bruno D'AgostinoFrancesco Rossi
May 13, 2010·The American Journal of Bioethics : AJOB·Charles E Murdoch, Christopher Thomas Scott
May 13, 2010·The American Journal of Bioethics : AJOB·Joanne ReimerJudy Illes
Jun 26, 2010·Science·Thomas H PetersenLaura E Niklason
Jun 26, 2010·Science·Dongeun HuhDonald E Ingber
Jun 29, 2010·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Jeremy Sugarman
Jul 16, 2010·Nature Medicine·Harald C OttJoseph P Vacanti
Dec 9, 2010·Nature Biotechnology·Amy ZarzecznyTimothy Caulfield
Jan 5, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yuben MoodleyDaniel J Weiss
Apr 9, 2011·Stem Cell Reviews and Reports·J IllesB K Kwon
Jan 10, 2012·Journal of Empirical Research on Human Research Ethics : JERHRE·R Jean CadiganLaura M Beskow
Mar 8, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Allison N LauDaniel J Weiss
Mar 13, 2012·Lancet·Stephen F BadylakPaolo Macchiarini
Mar 20, 2012·Critical Care : the Official Journal of the Critical Care Forum·Mairead HayesJohn G Laffey
Mar 23, 2012·European Journal of Clinical Investigation·Piero AnversaJoseph Loscalzo
Apr 21, 2012·American Journal of Respiratory and Critical Care Medicine·Darrell N Kotton
Nov 9, 2012·Science Translational Medicine·Dongeun HuhDonald E Ingber
Dec 1, 2012·Stem Cells Translational Medicine·Justin LowenthalSara Chandros Hull
Dec 5, 2012·Respiration; International Review of Thoracic Diseases·Demosthenes Bouros, Geoff Laurent
Dec 12, 2012·Science·Douglas Sipp, Leigh Turner
Dec 15, 2012·Nature Reviews. Drug Discovery·Charlotte Harrison
Dec 22, 2012·Respiration; International Review of Thoracic Diseases·George Kolios, Yuben Moodley
Jan 5, 2013·Kennedy Institute of Ethics Journal·Audrey R Chapman, Courtney C Scala
Jan 8, 2013·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Jeremy Sugarman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.